Pique Therapeutics, Inc. (Pique)

Oncology Corporate Profile

HQ Location

201 W. Main Street
Suite 300, PMB 317
Durham, NC 27701

Company Description

Pique Therapeutics is a biopharmaceutical company seeking to become the leader in the development and commercialization of new therapeutic vaccines, focused initially on the treatment of cancer. The Company was founded on the research of Eckhard R. Podack, M.D., Ph.D., who is Chair of the Department of Immunology and Microbiology at the University of Miami.

Website: http://piquetherapeutics.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
PT 107allogeneic B7.1/HLA-A1 transfected tumor cell vaccineNon Small Cell Lung Cancer (NSCLC)II
PT 128allogeneic B7.1/HLA-A1 transfected tumor cell vaccineColorectal cancerPreclinical
PT 207allogeneic B7.1/HLA-A1 transfected tumor cell vaccineHead & Neck cancerPreclinical
PT 123allogeneic B7.1/HLA-A1 transfected tumor cell vaccinePancreatic cancerPreclinical

View additional information on product candidates here »

Source: http://piquetherapeutics.com

Recent News Headlines

There are no news items to display